Trial intelligence / Profile preview

Oral midazolam versus oral ketamine for pediatric sedation before diagnostic imaging

IRCT20180708040396N1Phase 3Completed

Sponsor
Zahedan University of Medical Sciences
Start
Jul 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of midazolam and ketamine (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoint: Sedation. Started Jul 2018; status: completed.

02

Drugs

midazolamketamine

Beyond the preview

Go deeper on IRCT20180708040396N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180708040396N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call